Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,065.00
+6.00 (0.57%)
Jun 19, 2026, 1:44 PM IDT

TLV:REKA Balance Sheet

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.74.347.0319.3120.2118.6
Trading Asset Securities
-0.040.040.040.080.04
Cash & Short-Term Investments
6.744.387.0719.3520.2918.64
Cash Growth
-13.55%-38.09%-63.48%-4.63%8.83%-49.53%
Accounts Receivable
130.6126.35127.11117.68120.71107.37
Other Receivables
9.629.058.558.676.832.25
Receivables
140.22135.4135.66126.35127.54109.62
Inventory
92.9791.0182.4896.692.289.61
Prepaid Expenses
-1.72.631.941.831.42
Other Current Assets
-0.211.227.091.282.37
Total Current Assets
239.94232.68229.05251.33243.14221.66
Property, Plant & Equipment
121.82126.46140.07154.62163.21177
Long-Term Investments
1.321.171.181.17--
Goodwill
35.1435.1435.1435.1415.18-
Other Intangible Assets
20.1321.1225.731.6620.6732.97
Long-Term Deferred Tax Assets
3.667.116.0710.796.225.46
Other Long-Term Assets
---0.010.010.01
Total Assets
421.99423.68447.22484.72448.42437.09
Accounts Payable
101.1286.3787.2978.8981.2157.44
Accrued Expenses
-22.320.9823.9517.0513.61
Short-Term Debt
31.649.3914.353.12-0.01
Current Portion of Long-Term Debt
-15.8815.224.830.918.96
Current Portion of Leases
7.987.597.296.95.595.03
Current Income Taxes Payable
--0.351.560.760.26
Current Unearned Revenue
-0.230.240.130.10.25
Other Current Liabilities
22.8810.112.364.453.443.04
Total Current Liabilities
163.61151.87158.04143.79139.0398.61
Long-Term Debt
62.7168.563.62110.0991.66101.23
Long-Term Leases
29.4131.0333.738.7637.5540.6
Pension & Post-Retirement Benefits
11.2511.2610.589.748.869.22
Long-Term Deferred Tax Liabilities
1.474.945.276.032.753.16
Other Long-Term Liabilities
1211.8814.0220.746.4911.21
Total Liabilities
280.45279.47285.24329.14286.34264.03
Common Stock
13.6413.6413.6413.6413.6413.64
Additional Paid-In Capital
126.61126.61126.61126.61126.61126.61
Retained Earnings
0.723.3921.1914.6721.3532.73
Treasury Stock
-0.51-0.51-0.51-0.51-0.51-0.51
Comprehensive Income & Other
1.031.030.991.120.930.54
Total Common Equity
141.5144.16161.93155.54162.03173.01
Minority Interest
0.050.050.050.050.050.05
Shareholders' Equity
141.54144.21161.98155.59162.08173.07
Total Liabilities & Equity
421.99423.68447.22484.72448.42437.09
Total Debt
131.73132.39134.16183.66165.7165.82
Net Cash (Debt)
-124.99-128.01-127.09-164.31-145.41-147.18
Net Cash Per Share
-10.94-11.21-11.13-14.39-12.74-12.89
Filing Date Shares Outstanding
11.511.4111.4111.4111.4111.41
Total Common Shares Outstanding
11.511.4111.4111.4111.4111.41
Working Capital
76.3380.8271.01107.54104.11123.05
Book Value Per Share
12.3012.6314.1913.6314.1915.16
Tangible Book Value
86.2387.89101.0988.73126.18140.05
Tangible Book Value Per Share
7.507.708.867.7711.0512.27
Land
-1.891.891.892.072.07
Buildings
-120.11119.29117.94124.71122.66
Machinery
-130.24125.12121.03112.99109.84
Leasehold Improvements
-63.3463.1661.1558.2857.23